Clinical Trials Directory

Trials / Completed

CompletedNCT06884566

Effect of Acute Supplementation (taurine) on Maximal Strength and Anaerobic Power

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
17 (actual)
Sponsor
University of Central Lancashire Cyprus · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

This crossover-design study examines the acute effect of taurine on trained individuals aged 18-40 on strength and power outputs.

Detailed description

The purpose of this study is to further investigate any potential ergogenic effects offered by taurine, under specific conditions, namely that of acute supplementation, as opposed to the chronic supplementation protocols of many popular ergogenic aids, such as creatine and beta alanine. Exercise modes investigated include maximal isometric strength, maximal instantaneous power generation, and sustained maximal anaerobic power output, investigated via grip strength, vertical jump height, and the Wingate test, respectively.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTTaurine supplementationFor the intervention trials participants consumed the following in randomized order: 50mg·kg -1 of taurine diluted in 500ml of a sugar-free lemonade drink or placebo which was a sugar-free lemonade drink with nothing added, 60 minutes before the exercise protocols. Participants wore a nose plug during consumption to confirm that no taste differences were discernible between trials.
DIETARY_SUPPLEMENTPlaceboFor the intervention trials participants consumed the following in randomized order: 50mg·kg -1 of taurine diluted in 500ml of a sugar-free lemonade drink or placebo which was a sugar-free lemonade drink with nothing added, 60 minutes before the exercise protocols. Participants wore a nose plug during consumption to confirm that no taste differences were discernible between trials.

Timeline

Start date
2025-01-07
Primary completion
2025-01-21
Completion
2025-01-21
First posted
2025-03-19
Last updated
2025-03-19

Locations

1 site across 1 country: Cyprus

Source: ClinicalTrials.gov record NCT06884566. Inclusion in this directory is not an endorsement.